Tualang Honey formulation as potential osteoarthritis treatment: in-vitro genotoxicity outcome
INTRODUCTION: Osteoarthritis (OA) is a degenerative joint disease affecting millions worldwide. In the orthopaedic field, viscosupplementation is used as an option treatment for pain relief among osteoarthritis patients. Tualang Honey Formulation (THF) (Patent no. MY179303-A) is currently being st...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Malaysian Orthopaedic Association (MOA)
2024
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/116543/7/116543_Tualang%20honey%20formulation%20as%20potential%20Osteoarthritis%20treatment.pdf http://irep.iium.edu.my/116543/ https://www.morthoj.org/supplements/moa-2024/index.php |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|